Sildenafil Citrate Tablet, Film Coated
Product Images NDC 59762-0035

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 59762-0035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram of sildenafil citrate, showing its molecular components and arrangement as per the active ingredient in the labeled product.*

FDA Label Image

Figure 1: Mean Change From Baseline In Sitting Systolic Blood Pressure, Healthy Volunteers. (Image 02)

A line chart comparing sildenafil 100 mg and placebo, showing mean changes in systolic blood pressure (mmHg) over time post-dose up to 24 hours. The graph plots systolic blood pressure values on the vertical axis and time in hours on the horizontal axis for both treatments.*

FDA Label Image

Figure 2: Mean Standing Systolic Blood Pressure Change From Baseline (Image 03)

A line graph depicting change in mean seated blood pressure (mmHg) over a period of 8 hours postdose. Two data series are shown: one for Doxazosin plus Placebo and another for Doxazosin plus Sildenafil 25 mg. The x-axis represents time in hours after dosing, and the y-axis represents the change in blood pressure. The graph compares blood pressure changes between the two treatment groups.*

FDA Label Image

Figure 3: Mean Standing Systolic Blood Pressure Change From Baseline (Image 04)

A line graph showing change in a measured variable over time postdose (hours). Two data series are plotted: one for Doxazosin plus placebo and one for Doxazosin plus Sildenafil 50 mg, with the Sildenafil group showing generally less negative change compared to placebo over an 8-hour period.*

FDA Label Image

Figure 4: Mean Standing Systolic Blood Pressure Change From Baseline (Image 05)

A line graph showing the effect of doxazosin combined with sildenafil 100 mg versus doxazosin with placebo over time after dosing, measured in millimeters of mercury (mmHg) on the vertical axis and hours on the horizontal axis from 0 to 8 hours.*

FDA Label Image

Figure 5: Mean Sildenafil Plasma Concentrations In Healthy Male Volunteers. (Image 06)

A line graph titled 'Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' showing plasma concentration (ng/mL) versus time post dose (hours) for a commercial sildenafil tablet. The graph plots mean plasma concentrations over a 24-hour period, with concentrations peaking around 1 hour post dose and gradually decreasing thereafter.*

FDA Label Image

Figure 6. Effect Of Sildenafil Citrate And Placebo On Maintenance Of Erection By Baseline Score (Image 07)

Two bar charts illustrating the effect of Sildenafil Citrate and Placebo on maintenance of erection by baseline score. The charts show percentages of patients at endpoint across baseline scores from 0 to 5, with various score levels indicated by different bar shades. The upper chart represents Sildenafil Citrate, and the lower chart represents Placebo.*

FDA Label Image

Figure 7. Percentage Of Patients Reporting An Improvement In Erections. (Image 08)

A vertical bar chart showing the percentage of patients reporting improvement by treatment group for Sildenafil Citrate tablets in 25 mg, 50 mg, and 100 mg doses compared to placebo. The graph illustrates increasing improvement percentages with higher doses, with statistical significance noted as p<0.0001.*

FDA Label Image

Sildenafil Citrate Tablets 25 mg Bottle Lables (Image 09)

Label for Sildenafil Citrate 25 mg film-coated tablets by Mylan Pharmaceuticals Inc. The label indicates a 30-tablet package, branded as GREENSTONE® BRAND, with an Rx-only designation. Storage instructions specify 25°C with excursions permitted between 15-30°C. The product is distributed by Greenstone LLC and made in France.*

FDA Label Image

Sildenafil Citrate Tablets 50 mg Bottle Lables (Image 10)

Sildenafil citrate 50 mg film-coated tablets packaging label showing 100 tablets per bottle. Label features the Greenstone brand and indicates prescription only (Rx only). Distributed by Greenstone LLC, manufactured by Mylan Pharmaceuticals Inc. Instructions for storing at 25°C and dosage information are partially visible.*

FDA Label Image

Sildenafil Citrate Tablets 100 mg Bottle Lables (Image 11)

Sildenafil Citrate 100 mg film-coated tablets packaging label by Mylan Pharmaceuticals Inc. The label indicates a 100-tablet package, with storage instructions and dosage information. It features the Greenstone® brand name and a barcode, specifying the NDC 59762-0036-2, and states the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.